D016219ProceduresE02.095.465.425.400.330.050.400E05.478.550.520.050.40037817300.485543Immunotherapy, AdoptiveFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonLymphoma-MyelomaMD AndersonSATTVA SNEELAPUSATTVA S NEELAPU9154NEELAPU, SATTVA SAssociate Professor74Professor14Associate Professor42Director6Adjunct Professor47Distinguished Service Professor10.40820.00373154378research area of0.99470.0262911716subject area forDepartment of PediatricsPediatrics-Hem/Onc Cell & Gene ThePediatrics-Hematology & OncologyBaylor College of MedicineMALCOLMBRENNERMALCOLM BRENNER0.000000000000000.000000000000003564BRENNER, MALCOLMDistinguished Service ProfessorCLIONAROONEYCLIONA ROONEY0.000000000000000.000000000000003578ROONEY, CLIONAProfessorHELENHESLOPHELEN HESLOP0.000000000000000.000000000000003566HESLOP, HELENProfessorSTEPHENGOTTSCHALKSTEPHEN GOTTSCHALK0.000000000000000.0000000000000053GOTTSCHALK, STEPHENAdjunct Professortrue1Distinguished Service ProfessorDistinguished Service Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Adjunct ProfessorAdjunct Professor37983485Filosto S, Vardhanabhuti S, Canales MA, Poir? X, Lekakis LJ, de Vos S, Portell CA, Wang Z, To C, Schupp M, Poddar S, Trinh T, Warren CM, Aguilar EG, Budka J, Cheng P, Chou J, Bot A, Shen RR, Westin JRBlood cancer discoveryProduct Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7). Blood Cancer Discov. 2024 01 08; 5(1):21-33.Blood Cancer Discov2024-01-08T00:00:002024Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7).38098451Mai S, Hodges A, Chen HM, Zhang J, Wang YL, Liu Y, Nakatsu F, Wang X, Fang J, Xu Y, Davidov V, Kang K, Pingali SR, Ganguly S, Suzuki M, Konopleva M, Prinzing B, Zu Y, Gottschalk S, Lu Y, Chen SH, Pan PYCancer researchLILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy. Cancer Res. 2023 12 15; 83(24):4047-4062.Cancer Res2023-12-15T00:00:002023LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.38066908Nastoupil LJ, Kambhampati SHematology. American Society of Hematology. Education ProgramManagement of aggressive lymphoma after CAR T-cell therapy failure. Hematology Am Soc Hematol Educ Program. 2023 Dec 08; 2023(1):364-369.Hematology Am Soc Hematol Educ Program2023-12-08T00:00:002023Management of aggressive lymphoma after CAR T-cell therapy failure.38206641Naik S, Gottschalk SBloodIs immune escape in the rearview mirror? Blood. 2024 Jan 11; 143(2):97-98.Blood2024-01-11T00:00:002024Is immune escape in the rearview mirror?38423748Betof Warner A, Hamid O, Komanduri K, Amaria R, Butler MO, Haanen J, Nikiforow S, Puzanov I, Sarnaik A, Bishop MR, Schoenfeld AJJournal for immunotherapy of cancerExpert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy. J Immunother Cancer. 2024 Feb 29; 12(2).J Immunother Cancer2024-02-29T00:00:002024Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy.true1Associate ProfessorAssociate Professor